New Chair of the Dalton Transactions Editorial Board appointed
26 November 2007
RSC Publishing is delighted to announce the appointment of Professor Chris Orvig as Dalton Transactions Editorial Board Chair.
Chris' research activities include the study of the roles of metal ions in the etiology, diagnosis, and therapy of disease. These projects encompass a variety of metal ions as well as numerous ligand systems and a panoply of techniques and collaborations. His research also includes the synthesis of organic ligands and inorganic complexes as well as physical (potentiometric and spectrophotometric titrations, magnetochemistry, electrochemistry etc.) and biological studies. Specific areas of interest include: vanadium compounds as insulin enhancing pharmaceuticals, glycosylated pro-drugs for metal passivation in neurodegenerative diseases, carbohydrate conjugates in nuclear medicine, ferrocenyl-carbohydrate conjugates in malaria, and lanthanide compounds for bone resorption disorders.

Related Links
Interview: Orvig's marvellous medicine
Chris Orvig talks to May Copsey about his latest work in the treatment of diabetes and his love for teaching.
External links will open in a new browser window
Link to journal article
Metal complexes in medicinal chemistry: new vistas and challenges in drug design
Katherine H. Thompson and Chris Orvig, Dalton Trans., 2006, 761
DOI: 10.1039/b513476e
Lanthanide containing compounds for therapeutic care in bone resorption disorders
Cheri A. Barta, Kristina Sachs-Barrable, Jessica Jia, Katherine H. Thompson, Kishor M. Wasan and Chris Orvig, Dalton Trans., 2007, 5019
DOI: 10.1039/b705123a
Lanthanide(III) and group 13 metal ion complexes of tripodal amino phosphinate ligands
Michael S. Kovacs, Vishakha Monga, Brian O. Patrick and Chris Orvig, Dalton Trans., 2006, 31
DOI: 10.1039/b507905e
